Verucerfont Inhibitor

Verucerfont is an antagonist of corticotropin-releasing factor receptor 1 (CRF1).

Schwandt M L, Cortes C R, Kwako L E, et al. The CRF1 Antagonist Verucerfont in Anxious Alcohol Dependent Women: Translation of Neuroendocrine, but not of Anti-Craving Effects[J]. Neuropsychopharmacology, 2016.
Schwandt M L, Cortes C R, Kwako L E, et al. The CRF1 Antagonist Verucerfont in Anxious Alcohol Dependent Women: Translation of Neuroendocrine, but not of Anti-Craving Effects[J]. Neuropsychopharmacology, 2016.
Zorrilla E P, Heilig M, De Wit H, et al. Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism[J]. Drug and Alcohol Dependence, 2013, 128(3):175-186.
Zorrilla E P, Heilig M, De Wit H, et al. Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism[J]. Drug and Alcohol Dependence, 2013, 128(3):175-186.

Small volumes of Verucerfont, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5758298 is an inhibitor targeting Verucerfont.